2025 BioPharma Deals: The Survival Series | Nov 24-25 | Munich, Germany

BioPharma Deals: The Survival Series brings together leaders from biotech, pharma, investment, CRO/CDMO, legal, and advisory sectors for a high-impact event focused on pragmatic deal-making, new financing models, early IPOs, and unconventional partnerships.This is not a conference about the distant future. It's a working summit for what can be done now. It's about survival,…

BySaurabh ChaubeyAugust 18, 2025

NEWS

Ethris Partners with Lonza to Develop Intranasal Spray-Dried mRNA Vaccines Against Respiratory Diseases

Shots:Ethris has entered into a collaboration agreement with Lonza to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates designed for mucosal delivery in pts with respiratory diseasesAs per the deal, Lonza will support Ethris’ vaccine candidates, which are based on Ethris’ stabilized non-immunogenic mRNA (SNIM RNA) & stabilized lipid nanoparticles (SNaP LNP)…

ByRidhi RastogiApril 7, 2025

MAGAZINE

PharmaShots Magazine-March-2025 Edition

Did you know that 60 percent of pharmaceutical production is outsourced? As drug development costs rise, CDMOs have become safe havens for biopharma companies by offering scalable, cost-effective, and cutting-edge technology solutions for drug development and manufacturing. In March, PharmaShots Magazine is navigating the evolving Biopharma CDMO frontier by decoding trends, illustrative infographics, thought-provoking articles,…

ByAditya SinghMarch 13, 2025

TOP 20

20 Contract Development and Manufacturing Organizations (CDMO) of 2024

Shots:CDMOs are at the forefront of pharmaceutical manufacturing, shaping the industry's growth by meeting the increasing global demand for pharmaceutical productsIn 2023, the global CDMO market was valued at $224.86B, with projections to reach $465.14B by 2032, demonstrating a CAGR of 8.5%PharmaShots presents a comprehensive report on the 20 Contract Development and…

ByPrince GiriNovember 14, 2024

2025 BioPharma Deals: The Survival Series | Nov 24-25 | Munich, Germany

Ethris Partners with Lonza to Develop Intranasal Spray-Dried mRNA Vaccines Against Respiratory Diseases

PharmaShots Magazine-March-2025 Edition

20 Contract Development and Manufacturing Organizations (CDMO) of 2024

Contact US

OUR INFORMATION

FOLLOW US